University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

Trial of Home Visitation Among Infants With Failure To Thrive

Not Applicable

Completed

Conditions: Failure to Thrive

First Posted Date: 2007-06-07

Last Posted Date: 2020-04-14

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 130

Registration Number: NCT00483691

Locations: 🇺🇸
University of Maryland Growth and Nutrition Clinic, Baltimore, Maryland, United States

Effect of EGCG on the Body's Response to Insulin

Phase 2

Withdrawn

Conditions: Obesity
Insulin Resistance
Hypertension
Type 2 Diabetes

Interventions: Drug: EGCG

First Posted Date: 2007-02-13

Last Posted Date: 2022-03-04

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT00434499

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

Efficacy of Silymarin for Acute Hepatitis

Phase 4

Completed

Conditions: Hepatitis

First Posted Date: 2006-12-18

Last Posted Date: 2021-04-23

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 200

Registration Number: NCT00412763

BHS4 - Bone/Muscle Changes Following Hip Fracture in Older White Women

Not Applicable

Completed

Conditions: Hip Fracture

Interventions: Behavioral: Exercise Plus Program

First Posted Date: 2006-10-20

Last Posted Date: 2022-01-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 170

Registration Number: NCT00390741

Locations: 🇺🇸
Northwest Hospital Center, Randallstown, Maryland, United States
🇺🇸
Union Memorial Hospital, Baltimore, Maryland, United States
🇺🇸
St. Joseph's Hospital, Towson, Maryland, United States

Low Dose Upper Abdominal Radiation Therapy (LD-UART) + Gemcitabine in Patients With Advanced, Unresectable Pancreatic Cancer (PC)

Phase 1

Completed

Conditions: Ovarian Neoplasms
Gastrointestinal Neoplasms

Interventions: Drug: Gemcitabine

First Posted Date: 2006-10-19

Last Posted Date: 2020-03-18

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 38

Registration Number: NCT00390182

Locations: 🇨🇦
Juravinski Cancer Centre, Hamilton, Ontario, Canada
🇺🇸
University of Maryland & Baltimore VA medical centre, Baltimore, Maryland, United States

Effect of Chronic Changes in Heart Rate on Congestive Heart Failure

Not Applicable

Completed

Conditions: Heart Failure, Congestive

Interventions: Device: heart rate setting

First Posted Date: 2006-10-19

Last Posted Date: 2021-12-20

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 13

Registration Number: NCT00389649

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

BHS5 - Testing the Effectiveness of the Exercise Plus Program

Not Applicable

Completed

Conditions: Hip Fracture

Interventions: Behavioral: Exercise Trainer component of the Exercise Plus Program
Behavioral: Plus component (motivation) of the Exercise Plus Program
Behavioral: Exercise Plus Program (exercise + motivation)

First Posted Date: 2006-10-19

Last Posted Date: 2022-03-22

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 240

Registration Number: NCT00389844

Locations: 🇺🇸
Greater Baltimore Medical Center (GBMC), Baltimore, Maryland, United States
🇺🇸
Harbor Hospital Center, Baltimore, Maryland, United States
🇺🇸
St. Agnes Hospital, Baltimore, Maryland, United States

and more 2 locations

Clinical Trial of Dipyridamole in Schizophrenia

Not Applicable

Completed

Conditions: Schizophrenia
Schizoaffective Disorder
Schizophreniform Disorder

Interventions: Other: Olanzapine
Drug: Dipyridamole

First Posted Date: 2006-07-10

Last Posted Date: 2019-11-04

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 29

Registration Number: NCT00349973

Locations: 🇺🇸
Maryland Psychiatric Research Center, Baltimore, Maryland, United States

A Study to Evaluate of the Efficacy of Enfuvirtide During the Induction Phase of Therapy

Phase 4

Completed

Conditions: HIV Infections

Interventions: Drug: Efavirenz, lamivudine, and tenofovir
Drug: Enfuvirtide

First Posted Date: 2006-06-27

Last Posted Date: 2021-05-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 2

Registration Number: NCT00344760

Locations: 🇺🇸
University of Maryland, Institute of Human Virology, Baltimore, Maryland, United States

Safety and Durability ofTenofovir and a Cell Cycle Agent for Viral Suppression

Not Applicable

Completed

Conditions: AIDS
HIV Infections

First Posted Date: 2006-06-27

Last Posted Date: 2021-05-11

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 9

Registration Number: NCT00344981

Locations: 🇺🇸
University of Maryland, Institute of Human Virology, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy